About: Getting to the source: dendritic cells as therapeutic reagents for the treatment of patients with cancer

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Getting to the source: dendritic cells as therapeutic reagents for the treatment of patients with cancer Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 July 1997

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в липні 1997 (uk) im Juli 1997 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xunetu de 1997 (ast) scientific article published on 01 July 1997 (en)
publication date	wds:Q73554952-D450419A-F46C-4EA5-8AEC-39CCB62DCE6E
publication date	1997-07-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q73554952-8E2C34C7-3757-4202-ACED-A198DEC9D3BF
language of work or name	English
cites work	wds:Q73554952-0F09925C-E66E-458B-869A-37700EB82B7B wds:Q73554952-10AD4360-132C-4B5A-83F0-BB526B604F04 wds:Q73554952-13C7019D-C932-4C69-A902-D6CCF0FCBADE wds:Q73554952-160DDC60-19D4-4868-B512-0FCF5013C059 wds:Q73554952-194FE65B-6B8A-4C6F-93DD-787BBD7F8F3E wds:Q73554952-208EBDFE-19FD-40D6-A718-F6ED55F2D5C5 wds:Q73554952-24C5768B-4FAD-406E-A386-F99C81239A16 wds:Q73554952-2B162BAF-EE27-424D-8A09-4FB0C09AA4E7 wds:Q73554952-2F26B078-63B3-4708-B904-C53AD5209FE8 wds:Q73554952-325DBA2C-F9D6-491A-A091-A383D4883519 wds:Q73554952-361E413E-168F-46D8-BCE7-F66AC96FBDF2 wds:Q73554952-3B8DDB68-4185-4B77-A35B-34F2674D392A wds:Q73554952-3C7A584E-5B56-4382-B7C8-7C6650E56C60 wds:Q73554952-3D0ED704-B0F9-4537-B0C9-A77E2248011C wds:Q73554952-40A623B7-A325-44A2-B37B-B37CADA42513 wds:Q73554952-4E0295EA-DE7B-4B96-9FB8-CB1C14AAC5C5 wds:Q73554952-5286B797-3822-49BD-970E-1CA8CF1CB5A3 wds:Q73554952-52ACAD05-1ACB-458E-A9EC-9D168BD13332 wds:Q73554952-52F8C054-A1D7-42EA-92C0-9CF8A09CCA30 wds:Q73554952-562BD357-3300-4DC5-9748-5F3A03FD6C99 wds:Q73554952-5C6F20EE-FD51-4C7F-BB40-29D80157086C wds:Q73554952-5D931E9D-B2FA-4E39-A2E5-3AC3DD597D22 wds:Q73554952-6D846855-D8E8-4B53-B128-D0F472D9ED69 wds:Q73554952-6EECD04D-D8D2-4601-A15B-184D59610399 wds:Q73554952-7C9C41B7-B9A9-4520-9EBE-6716D2E60122 wds:Q73554952-7FDE21FE-AA20-4E99-8C64-2057F6F2A1CE wds:Q73554952-8309C2A3-DC39-4E9E-9E30-11369B85BA53 wds:Q73554952-8A16721A-E7C1-4752-9BFD-653D6039A18A wds:Q73554952-8D3B9E37-6803-435B-BA99-11EABF4D9BE6 wds:Q73554952-91F66DF6-4190-49A8-8105-D9B9D1535F58 wds:Q73554952-925CAC3E-CBD1-4214-840E-E869702B956A wds:Q73554952-A36DB678-CA12-4F00-B994-F89145C654EA wds:Q73554952-A92781D9-AEEE-41A2-9877-C632A04076AC wds:Q73554952-B200A9E0-1970-44AB-ADCB-84EB185DF1AC wds:Q73554952-B27B7DB9-74E6-4D12-A132-421CFA898A04 wds:Q73554952-BCDC382A-3DB9-4497-9236-FE6EEF7F4736 wds:Q73554952-C08846A2-A503-415B-AC71-5BDAC186E370 wds:Q73554952-CC4F8456-9BBC-417E-9DA5-CD27CDF069B6 wds:Q73554952-D008F6FB-34CC-472E-9F0D-3DFEE3D6EB54 wds:Q73554952-FA7AB128-BD0D-4383-B028-609B80FC7232
cites work	Local expression of transgene encoded TNF alpha in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells Differentiation of human dendritic cells from monocytes in vitro. Evidence that granulocyte macrophage-colony-stimulating factor regulates the distribution and differentiated state of dendritic cells/Langerhans cells in human lung and lung cancers Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. Fascin, a sensitive new marker for Reed-Sternberg cells of hodgkin's disease. Evidence for a dendritic or B cell derivation? Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha DNA-based immunization by in vivo transfection of dendritic cells Granulocytes, macrophages, and dendritic cells arise from a common major histocompatibility complex class II-negative progenitor in mouse bone marrow Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion? Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures CD40 ligation on human cord blood CD34+ hematopoietic progenitors induces their proliferation and differentiation into functional dendritic cells Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells T cell-derived IL-4 and dendritic cell-derived IL-12 regulate the lymphokine-producing phenotype of alloantigen-primed naive human CD4 T cells Dendritic cells and tolerance induction. Proliferating dendritic cell progenitors in human blood The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand Human lung carcinomas express Fas ligand. Long-lasting CD8 T cell memory in the absence of CD4 T cells or B cells. Bacillus Calmette-Guérin mycobacteria stimulate human blood dendritic cells Sorting out the cytokines of asthma Expression of relB is required for the development of thymic medulla and dendritic cells Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity Systemic injection of a tripeptide inhibits the intracellular activation of CPP32-like proteases in vivo and fully protects mice against Fas-mediated fulminant liver destruction and death Therapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccines Dendritic cells as initiators of tumor immune responses: a possible strategy for tumor immunotherapy? Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes A distinct pattern of cytokine gene expression by human CD83+ blood dendritic cells Enhanced tumor outgrowth after peptide vaccination. Functional deletion of tumor-specific CTL induced by peptide vaccination can lead to the inability to reject tumors TGF-beta 1 promotes in vitro development of dendritic cells from CD34+ hemopoietic progenitors Dendritic cells produce macrophage inflammatory protein-1 gamma, a new member of the CC chemokine family Aberrant antigen presentation by macrophages from tumor-bearing mice is involved in the down-regulation of their T cell responses
author name string	wds:Q73554952-BDA893A1-EC90-467A-88B6-10F0470374A6
author name string	M T Lotze
rdfs:label	Getting to the source: dendritic cells as therapeutic reagents for the treatment of patients with cancer (en) Getting to the source: dendritic cells as therapeutic reagents for the treatment of patients with cancer (nl)
skos:prefLabel	Getting to the source: dendritic cells as therapeutic reagents for the treatment of patients with cancer (en) Getting to the source: dendritic cells as therapeutic reagents for the treatment of patients with cancer (nl)
name	Getting to the source: dendritic cells as therapeutic reagents for the treatment of patients with cancer (en) Getting to the source: dendritic cells as therapeutic reagents for the treatment of patients with cancer (nl)
title	wds:Q73554952-FD4490A2-2943-4D03-B80A-C6403C4FDE97
title	Getting to the source: dendritic cells as therapeutic reagents for the treatment of patients with cancer (en)

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software